TR200002808T2 - İlaç olarak yararlı C11 oksimil ve hidroksilamino prostaglandinleri - Google Patents

İlaç olarak yararlı C11 oksimil ve hidroksilamino prostaglandinleri

Info

Publication number
TR200002808T2
TR200002808T2 TR2000/02808T TR200002808T TR200002808T2 TR 200002808 T2 TR200002808 T2 TR 200002808T2 TR 2000/02808 T TR2000/02808 T TR 2000/02808T TR 200002808 T TR200002808 T TR 200002808T TR 200002808 T2 TR200002808 T2 TR 200002808T2
Authority
TR
Turkey
Prior art keywords
compounds
oximyl
medicines
glaucoma
treatment
Prior art date
Application number
TR2000/02808T
Other languages
English (en)
Inventor
Anthony Delong Mitchell
Jack Snyder Amburgey, Jr.
August Wos John
De Biswanath
Lindsey Soper David
Original Assignee
The Procter & Gamble Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Procter & Gamble Company filed Critical The Procter & Gamble Company
Publication of TR200002808T2 publication Critical patent/TR200002808T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40—Radicals substituted by oxygen atoms
    • C07D307/42—Singly bound oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C239/00—Compounds containing nitrogen-to-halogen bonds; Hydroxylamino compounds or ethers or esters thereof
    • C07C239/08—Hydroxylamino compounds or their ethers or esters
    • C07C239/18—Hydroxylamino compounds or their ethers or esters having nitrogen atoms of hydroxylamino groups further bound to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/32—Oximes
    • C07C251/34—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C251/44—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with the carbon atom of at least one of the oxyimino groups being part of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/16—Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Bulus yeni PGF analoglari saglar. Özellikle, mevcut bulus formül (I)'e göre bir yapiya sahip olan bilesikler ile ilgilidir: ki burada, R1, R2, R3, R4, R5, R6, W, X, Z, a, b, ve p asagida tanimlanmaktadir. Bu bulus ayrica yukaridaki formülün optik izomerlerini, diastereomerlerini ve enantiomerlerini, ve bunlarin farmasötik olarak kabul edilen tuzlarini, biyolojik olarak hidroliz edilebilen amidlerini, esterlerini ve imidlerini de içerir. Mevcut bulusun bilesikleri, kemik bozukluklari ve glokom gibi çesitli hastaliklarin ve kosullarin tedavisi için yararlidir. Buna parelel olarak , bulus ayrica, bu bilesikleri içeren farmasötik bilesimler saglar. Bulus yine ayrica bu bilesikleri veya bunlari içeren bilesimleri kullanarak kemik bozukluklari ve glokomun tedavisi için yöntemler saglar.
TR2000/02808T 1998-03-31 1999-03-22 İlaç olarak yararlı C11 oksimil ve hidroksilamino prostaglandinleri TR200002808T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8007598P 1998-03-31 1998-03-31

Publications (1)

Publication Number Publication Date
TR200002808T2 true TR200002808T2 (tr) 2001-01-22

Family

ID=22155104

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/02808T TR200002808T2 (tr) 1998-03-31 1999-03-22 İlaç olarak yararlı C11 oksimil ve hidroksilamino prostaglandinleri

Country Status (23)

Country Link
US (1) US6410780B1 (tr)
EP (1) EP1082299B1 (tr)
JP (1) JP2002509915A (tr)
KR (1) KR20010042286A (tr)
CN (1) CN1295560A (tr)
AR (1) AR020063A1 (tr)
AT (1) ATE270272T1 (tr)
AU (1) AU749796B2 (tr)
BR (1) BR9909267A (tr)
CA (1) CA2324343C (tr)
DE (1) DE69918433T2 (tr)
ES (1) ES2223180T3 (tr)
HU (1) HUP0102789A2 (tr)
ID (1) ID26699A (tr)
IL (1) IL138446A0 (tr)
NO (1) NO20004904L (tr)
NZ (1) NZ506853A (tr)
PE (1) PE20000350A1 (tr)
PL (1) PL343113A1 (tr)
SK (1) SK14732000A3 (tr)
TR (1) TR200002808T2 (tr)
WO (1) WO1999050241A1 (tr)
ZA (1) ZA992393B (tr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4834224B2 (ja) 1999-03-05 2011-12-14 デューク ユニバーシティ Ｃ１６不飽和ｆｐ−選択的プロスタグランジン類縁体
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US20020146439A1 (en) * 2000-03-31 2002-10-10 Delong Mitchell Anthony Compositions and methods for treating hair loss using oximyl and hydroxylamino prostaglandins
US20020037914A1 (en) 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
JP2008517941A (ja) * 2004-10-21 2008-05-29 デューク・ユニバーシティー 眼科用薬剤
US20070254920A1 (en) * 2006-04-26 2007-11-01 Aerie Pharmaceuticals, Inc. Prodrug derivatives of acids using alcohols with homotopic hydroxy groups and methods for their preparation and use
US8722739B2 (en) 2008-10-29 2014-05-13 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US8623918B2 (en) * 2008-10-29 2014-01-07 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US20110293549A1 (en) 2009-02-03 2011-12-01 Athena Cosmetics, Inc. Composition, method and kit for enhancing hair
CN102101835B (zh) * 2009-12-16 2015-07-22 武汉启瑞药业有限公司 前列腺素衍生物及其中间体的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3776938A (en) 1958-05-28 1973-12-04 S Bergstrom Dihydro-pge1
US3636120A (en) 1967-10-09 1972-01-18 Upjohn Co Prostaglandin e primary alcohols
US4011262A (en) 1972-07-13 1977-03-08 Pfizer Inc. 13,14-Dihydro-15-substituted-ω-pentanorprostaglandins of the two series
US4024179A (en) 1972-11-08 1977-05-17 Pfizer Inc. Substituted ω-pentanorprostaglandins
DE2460990A1 (de) 1974-12-21 1976-07-01 Hoechst Ag Neue prostaglandin-analoga und verfahren zu ihrer herstellung
GB1507211A (en) 1975-02-14 1978-04-12 Ono Pharmaceutical Co Prostaglandin analogues
JPH0222226A (ja) 1988-07-12 1990-01-25 Ono Pharmaceut Co Ltd Ｐｇｄ類似化合物を有効成分として含有する骨疾患治療剤
ES2317964T5 (es) 1988-09-06 2015-02-20 Pfizer Health Ab Derivado de prostaglandina-F2alfa para el tratamiento de glaucoma o hipertensión ocular

Also Published As

Publication number Publication date
EP1082299B1 (en) 2004-06-30
AU749796B2 (en) 2002-07-04
BR9909267A (pt) 2000-11-21
ID26699A (id) 2001-02-01
CN1295560A (zh) 2001-05-16
NZ506853A (en) 2002-09-27
CA2324343C (en) 2005-05-31
SK14732000A3 (sk) 2001-04-09
NO20004904D0 (no) 2000-09-29
KR20010042286A (ko) 2001-05-25
HUP0102789A2 (hu) 2001-12-28
DE69918433D1 (de) 2004-08-05
US6410780B1 (en) 2002-06-25
AU3270199A (en) 1999-10-18
CA2324343A1 (en) 1999-10-07
ATE270272T1 (de) 2004-07-15
WO1999050241A1 (en) 1999-10-07
EP1082299A1 (en) 2001-03-14
JP2002509915A (ja) 2002-04-02
IL138446A0 (en) 2001-10-31
AR020063A1 (es) 2002-04-10
NO20004904L (no) 2000-11-29
ES2223180T3 (es) 2005-02-16
ZA992393B (en) 1999-09-03
DE69918433T2 (de) 2005-09-01
PE20000350A1 (es) 2000-06-22
PL343113A1 (en) 2001-07-30

Similar Documents

Publication Publication Date Title
TR200000671T2 (tr) FP agonistleri olarak yararlı aromatik C16-C20-ikameli tetrahidro prostaglandinler.
TR200000670T2 (tr) FP agonistleri olarak yararlı aromatik C16-C20- ikameli tetrahidro prostaglandinler.
TR200000673T2 (tr) FP agonistleri olarak yararlı aromatik C16-C20- ikameli tetrahidro prostaglandinler.
EA200100553A1 (ru) Замещенные бициклические производные, полезные в качестве противораковых агентов
FI931888A0 (fi) Kramploesande cykliska fruktopyranossulfiter -och sulfater
MA27582A1 (fr) Derives benzazepine pour le traitement de troubles neurologiques
NO170280C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive sulfamatderivater
ES533338A0 (es) Derivados de la 2-pirimidinil-1-piperazina
EA200100135A1 (ru) Алкинилзамещенные производные хинолин-2-она, полезные в качестве противораковых агентов
ES8403858A1 (es) Procedimiento para la preparacion de dipeptidos carboxialquilicos.
EP0896533A4 (en) PENTAFLUOROBENZEN SULPHONAMIDES AND ANALOGS
ATE103812T1 (de) Zusammensetzung zur behandlung von ischaemischen stoerungen in organen.
TR200002971T2 (tr) İkameli pirolidin hidroksamat metaloproteaz inhibitörleri
FR2381763A1 (fr) Dibenzo(b-e) (diazepines-1,4) et leur utilisation comme antischizophreniques
HUT56077A (en) Process for producing n-(imidazolyl-alkyl)-alanyl derivatives with substituents and pharmaceutical compositions containing them as active components
TR200002808T2 (tr) İlaç olarak yararlı C11 oksimil ve hidroksilamino prostaglandinleri
EA200100516A1 (ru) Производные 3,3-биарилпиперидина и 2,2-биарилморфолина
ES8706654A1 (es) Un procedimiento para la preparacion de nuevos derivados de benzotiazina
ES2202156T3 (es) Nuevos analogos de 2-descarboxi-2-fosfinico prostaglandina f.
ATE19773T1 (de) Nitroaliphatische verbindungen, verfahren zu deren herstellung und deren verwendung.
CA2364944A1 (en) C16 unsaturated fp-selective prostaglandins analogs
ES8605507A1 (es) Un compuesto de 3-indolcarboxamida
CA2324590A1 (en) C11 oxymyl and hydroxylamino prostaglandins useful as fp agonists
NO164474C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive heksahydropyrrolo(2,1-a)isokinolin-derivater.
DE69527854D1 (de) Derivate substituierter amidinonaphthylester